MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
101.59
+0.34
+0.34%
After Hours: 101.59 0 0.00% 19:30 11/13 EST
OPEN
101.43
PREV CLOSE
101.25
HIGH
101.75
LOW
101.20
VOLUME
758.04K
TURNOVER
--
52 WEEK HIGH
111.86
52 WEEK LOW
50.16
MARKET CAP
6.64B
P/E (TTM)
24.58
1D
5D
1M
3M
1Y
5Y
1D
Lantheus selling its CDMO business and NJ manufacturing facility to PharmaLogic
TipRanks · 3d ago
Lantheus to Sell CDMO Business to PharmaLogic
TipRanks · 3d ago
PharmaLogic Agrees to Buy Lantheus' CDMO Business, N.J. Facility
Dow Jones · 4d ago
PharmaLogic Holdings Agrees To Acquire Lantheus Holdings' CDMO Operations, Springfield Production Site; Financial Terms Not Disclosed
Benzinga · 4d ago
*PharmaLogic: Move Expands U.S. Therapeutic Manufacturing Capacity and Creates the First Transatlantic CDMO Platform With a Proven Comml Track Record in Radioligand Therapies >LNTH
Dow Jones · 4d ago
*PharmaLogic: Financial Terms of the Transaction Were Not Disclosed >LNTH
Dow Jones · 4d ago
*PharmaLogic: To Acquire Lantheus' Contract Development and Manufacturing Organization Business and Springfield, N.J., Manufacturing Facility
Dow Jones · 4d ago
PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility
PR Newswire · 4d ago
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. Its product categories include oncology, neurology, cardiology, and strategic partnerships and others. Its products include PYLARIFY, Neuraceq, and DEFINITY. PYLARIFY TruVu is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA). Neuraceq is an Alzheimer's disease radiodiagnostic. Its commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists across a range of clinical care settings. Its diagnostic products provide information that enables healthcare professionals (HCPs) to better detect, characterize, or rule out diseases.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.